Home/Filings/4/0001493152-20-011536
4//SEC Filing

Jabbour Jerome D 4

Accession 0001493152-20-011536

CIK 0001582554other

Filed

Jun 18, 8:00 PM ET

Accepted

Jun 19, 5:30 PM ET

Size

5.7 KB

Accession

0001493152-20-011536

Insider Transaction Report

Form 4
Period: 2020-06-17
Jabbour Jerome D
DirectorPresident and CEO
Transactions
  • Award

    Stock option (right to buy)

    2020-06-17+500,000500,000 total
    Exercise: $0.81Exp: 2030-06-16Common Stock (500,000 underlying)
Footnotes (1)
  • [F1]The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. Vesting is performance based and tied to achievement of positive topline ENHANCE-IT data (the "Milestone"). The option vests as to 1/3 upon achievement of the Milestone, with the remaining options to vest 1/3 on the first anniversary of such Milestone and 1/3 on the second anniversary of such Milestone.

Documents

1 file

Issuer

Matinas BioPharma Holdings, Inc.

CIK 0001582554

Entity typeother

Related Parties

1
  • filerCIK 0001698838

Filing Metadata

Form type
4
Filed
Jun 18, 8:00 PM ET
Accepted
Jun 19, 5:30 PM ET
Size
5.7 KB